Effectiveness of monovalent rotavirus vaccine in the Philippines 13 th Rotavirus Symposium, 29 Aug 2018, Minsk, Belarus
|
|
- Archibald Armstrong
- 5 years ago
- Views:
Transcription
1 Effectiveness of monovalent rotavirus vaccine in the Philippines 13 th Rotavirus Symposium, 29 Aug 2018, Minsk, Belarus Anna Lena Lopez, MD, MPH Director, Institute of Child Health and Human Development, University of the Philippines Manila
2 Outline Introduction Methods Results Summary Declaration: I have no conflicts of interest.
3 INTRODUCTION
4 The Philippines Lower middle income country - GDP of 2,989.0 current USD Estimated Population, million
5 Rotavirus Accounts for ~40% of diarrheal hospitalizations in children <5 years worldwide Philippines: Diarrhea is the 2 nd leading cause of death in children 1-4 years of age and 8 th leading cause of death in infants a In 2013, Estimated 5,169 diarrhoea deaths, 50% were due to rotavirus or 2,599 deaths among children <5 years b 2017:1,394 (35%) confirmed cases a 2014 Health statistics b Tate J, et al. Clinical Infectious Diseases 2016;62(S2):S96 105
6 Rotavirus vaccine use in the Philippines 2006 Recommended by the Pediatric Society for the private sector in the Philippines for routine infant immunization; Private sector coverage according to EPI is estimated to be <10% of eligible population 2012 DOH announced inclusion of rotavirus vaccine in the EPI for babies aged 6 weeks to 15 weeks to receive the first dose in families from the poorest quintile 2014 Limited to 2 regions for effectiveness evaluation 2015 Further limited to one region (CARAGA region) to babies aged at least 6 weeks for the first dose. The second dose given at least 4 weeks after the 1st dose, together with second dose of Pentavalent and OPV, as long as less than 2 years of age.
7 Rotavirus Vaccine Effectiveness Evaluation Objective: To estimate the effectiveness of rotavirus vaccine in the Philippines Conducted within an ongoing rotavirus surveillance Rotavirus Surveillance Established in 2012 in 7 sentinel hospitals CARAGA Region (Region 13) had highest number of diarrhea cases reported
8
9 Rotavirus vaccination in Agusan del Sur September 2012 RV vaccine provided to infants in the poorest quintile in Agusan del Sur January 2013 RV vaccination expanded to all ageeligible children in two municipalities in Agusan del Sur, San Francisco and Prosperidad, regardless of socioeconomic status. July 2014 RV vaccination further expanded to all ageeligible children in the whole province Vaccine stock-outs occurred in October 2013 to June 2014 and from June 2016 to April 2017.
10 METHODS
11 Design: Test-negative case-control Within the rotavirus surveillance platform of D.O. Plaza Memorial Hospital Inclusion: Children aged <5 years who underwent treatment for acute diarrhea in DOPH were included in the surveillance Eligible to have received the rotavirus vaccine Resident of Agusan del Sur Methods
12 Definitions Acute diarrhea defined as the passage of three or more loose or watery stools within a 24-hour period for 14 days. Case-patients children enrolled in the active surveillance platform, who tested positive for RV by ELISA, and were age-eligible to have received RV vaccine. Controls children enrolled in the active surveillance platform who tested negative for RV by ELISA, and were age-eligible to have received RV vaccine.
13 RESULTS
14 Results From September 2014 to August 2016, screened 967 children Enrolled 600 children with stools tested for rotavirus and immunization status were confirmed 203 (34%) tested positive for RV Rotavirus Positive Rotavirus Negative n=203 (%) n=397 (%) p- value Median age in months (range) 11 (1-51) 11 (1-47) 0.07 Male 116 (57%) 233 (59%) 0.72 Household enrolled in 33 (16%) NHTS 60 (15%) 0.71 Median number of people in household 5 (3-14) 5 (3-15) 0.09 Mother s current age 29 (15-29 (16-47) (range) 47) 0.33 Mother's education level 0.28 Primary school 45 (22%) 90 (23%) Secondary school 131 (65%) 246 (62%) Post-secondary 15 (7%) 21 (5%) University or above 12 (6%) 40 (10%)
15 Clinical characteristics of enrolled children Rotavirus Positive Rotavirus Negative n=203 (%) n=397 (%) p-value Duration of diarrhea days 43 (21%) 100 (25%) 1-4 days 151 (74%) 272 (69%) 5 days 3 (2%) 13 (3%) 6 days 6 (3%) 12 (3%) Max number of <0.001 diarrhea episodes in 24 hours 1-3 episodes 30 (15%) 89 (22%) 4-5 episodes 89 (44%) 228 (57%) 6 episodes 84 (41%) 80 (20%)
16 Clinical characteristics of enrolled children Rotavirus Positive Rotavirus Negative n=203 (%) n=397 (%) p-value History of fever (% 162 (80%) 277 (70%) 0.01 yes) Vesikari Score (mild) 138 (68%) 303 (76%) (moderate) 64 (32%) 91 (23%) 15 (severe) 1 (1%) 3 (1%) Median Vesikari 10 (6-15) 9 (4-17) <0.001 Score (range) Child received any 0.10 vaccine Yes 157 (77%) 329 (83%)
17 Children s age at RV vaccination, by RV results
18 RV vaccine effectiveness among children RV vaccine doses 8 months who were ever vaccinated Rotavirus positive n (%) Rotavirus negative n (%) Unadjusted VE (95% CI) Adjusted VE* (95% CI) n=118 n=221 0 doses 29 (25%) 25 (11%) ref ref 1 dose 11 (9%) 19 (9%) 50% (-25%, 80%) 40% (-66%, 78%) 2 doses 78 (66%) 177 (80%) 62% (31%, 79%) 62% (26%, 80%) Any dose 89 (75%) 196 (89%) 61% (29%, 78%) 60% (24%, 79%) *Adjusted for month/year of birth, month/year admission, and district where child lives
19 Summary The monovalent RV vaccine had a 60% effectiveness against RV diarrhea in the Philippines Supports an earlier analysis showing a decline in diarrheal hospitalizations and diarrheal consultations in the whole province Results have been presented to the Philippines Department of Health in support of expanding use of the RV vaccine
20 Acknowledgemen ts WHO Regional Office for the Western Pacific Region US Centers for Disease Control and Prevention DOH-Expanded Programme for Immunization (EPI) DOH-Epidemiology Bureau Research Institute for Tropical Medicine Province of Agusan Del Sur DO Plaza Memorial Hospital CARAGA Region EPI CARAGA Regional Surveillance Unit
21 Thank you!
Rotavirus vaccine impact on diarrhea associated child mortality, hospital admissions & clinical visits in Bolivia
Rotavirus vaccine impact on diarrhea associated child mortality, hospital admissions & clinical visits in Bolivia Lucia Inchauste, Nataniel Mamani, Sonia Jimenez, Raul Montesano, Maritza Patzi, Rita Revollo,
More informationRotavirus: WHO Global Recommendations, Policy, and Surveillance
Rotavirus: WHO Global Recommendations, Policy, and Surveillance 9 th International Rotavirus Symposium 2 August 2010 Mary Agócs, MD, MSc Department of Immunization, Vaccines & Biologicals From 1999 2009:
More informationSamir K Saha, Ph.D Child Health Research Foundation Dhaka Shishu Hospital Dhaka, Bangladesh
Barriers Rotavirus to Rotavirus Vaccine Impact Vaccine Beyond Preventing Introduction Diarrhea Samir K Saha, Ph.D Child Health Research Foundation Dhaka Shishu Hospital Dhaka, Bangladesh 13 th International
More informationShabir A. Madhi. Progress and Challenges of Immunization Contributing Toward Attaining the MDG Goal to Reduce under-5 Childhood Mortality.
Shabir A. Madhi Progress and Challenges of Immunization Contributing Toward Attaining the MDG Goal to Reduce under-5 Childhood Mortality. National Institute for Communicable Diseases & University of Witwatersrand,
More informationUpdate on Pentavalent Human-Bovine Rotavirus Vaccine. Michelle Goveia, MD, MPH Medical Director MSD Vaccines India, September 2014
Update on Pentavalent Human-Bovine Rotavirus Vaccine Michelle Goveia, MD, MPH Medical Director MSD Vaccines India, September 2014 Outline Characteristics of RotaTeq and its worldwide use Recent data evaluating
More informationHerd Protection- Efficacy vs effectiveness The Importance of Cluster-Randomized Trials to assess Vaccine Herd Protection
Herd Protection- Efficacy vs effectiveness The Importance of Cluster-Randomized Trials to assess Vaccine Herd Protection Anna Lena Lopez, MD, MPH University of the Philippines Manila- National Institutes
More informationHousehold transmission of rotavirus in Malawian children with acute gastroenteritis is associated with disease severity
Household transmission of rotavirus in Malawian children with acute gastroenteritis is associated with disease severity Dr Aisleen Bennett International Rotavirus Symposium, Minsk, Belarus August 2018
More informationRotavirus serotype surveillance: Results and experiences in Tanzania. Adolfine Hokororo. KPA Vaccinology Symposium- 29 th April
Rotavirus serotype surveillance: Results and experiences in Tanzania Adolfine Hokororo KPA Vaccinology Symposium- 29 th April 2016 1 outline 1. Introduction-burden of RVGE 2. goals of RVGE sentinel surveillance
More informationNorthwestern Health Unit
Northwestern Health Unit www.nwhu.on.ca 210 First Street North Kenora Ontario P9N 2K4 1-800-830-5978 July 26, 2018 Re: Ontario Rotavirus Immunization Program - Transitioning to RotaTeq (Rot-5) pentavalent
More informationUsing surveillance data to monitor impact of rotavirus vaccine. Lúcia De Oliveira Regional Advisor on New Vaccines IM/PAHO
Using surveillance data to monitor impact of rotavirus vaccine Lúcia De Oliveira Regional Advisor on New Vaccines IM/PAHO Main Topics Epidemiological surveillance of rotavirus in American Region Impact
More informationValue of post-licensure data to assess public health value Example of rotavirus vaccines
Value of post-licensure data to assess public health value Example of rotavirus vaccines TM Umesh D. Parashar Lead, Viral Gastroenteritis Team CDC, Atlanta, USA uparashar@cdc.gov 1 Two New Rotavirus Vaccines
More informationGSK Medicine: Study No.: Title: Rationale: Study Period Objectives: Indication: Study Investigators/Centers: Research Methods: Data Source:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationImpact of Rotavirus Vaccination on Diarrheal Hospitalizations in Children Aged <5 Years in Lusaka, Zambia
Clinical Infectious Diseases SUPPLEMENT ARTICLE Impact of Rotavirus Vaccination on Diarrheal Hospitalizations in Children Aged
More informationWHO-Coordinated Global Rotavirus and Pediatric Diarrhea Surveillance
WHO-Coordinated Global Rotavirus and Pediatric Diarrhea Surveillance Adam L. Cohen Thirteenth International Rotavirus Symposium Minsk, Belarus 29 August 2018 Why do countries conduct vaccine-preventable
More informationVaccines against Rotavirus & Norovirus. Umesh D. Parashar CDC, Atlanta, GA
TM Vaccines against Rotavirus & Norovirus Umesh D. Parashar CDC, Atlanta, GA 1 Rotavirus is the Leading Cause Of Severe Diarrhea in Children
More informationEffectiveness of rotavirus vaccination Generic study protocol for retrospective case control studies based on computerised databases
TECHNICAL DOCUMENT Effectiveness of rotavirus vaccination Generic study protocol for retrospective case control studies based on computerised databases www.ecdc.europa.eu ECDC TECHNICAL DOCUMENT Effectiveness
More informationGavi Alliance Strategy : Goal level indicators and disease dashboard
Gavi Alliance Strategy 2016-2020: Goal level indicators and disease dashboard BOARD MEETING Peter Hansen and Hope Johnson 10-11 June 2015, Geneva Reach every child www.gavi.org Strategic enablers Goal-level
More informationFrequently asked questions (FAQs) on MR vaccination campaign
Frequently asked questions (FAQs) on MR vaccination campaign What are measles/rubella diseases? Measles is a highly infectious disease causing illness and death due to complications in the form of diarrhea,
More informationRotavirus vaccines: Issues not fully addressed in efficacy trials
Rotavirus vaccines: Issues not fully addressed in efficacy trials TM Umesh D. Parashar Lead, Viral Gastroenteritis Team CDC, Atlanta, USA uparashar@cdc.gov 1 Two New Rotavirus Vaccines Licensed in 2006
More informationPart I. Health-related Millennium Development Goals
11 1111111111111111111111111 111111111111111111111111111111 1111111111111111111111111 1111111111111111111111111111111 111111111111111111111111111111 1111111111111111111111111111111 213 Part I Health-related
More informationWhose Child is not Immunized Trends in Prevalence and Predictors in Child Health Care. Evidence from DHDSS.
10 th INDEPTH AGM, 27 th -30 th September, 2010 ACCRA-GHANA Whose Child is not Immunized Trends in Prevalence and Predictors in Child Health Care. Evidence from DHDSS. Ottie-Boakye D., A. Manyeh, M. Gyapong
More informationRotavirus Vaccine Impact and Effectiveness in Armenia and Moldova
Rotavirus Vaccine Impact and Effectiveness in Armenia and Moldova Margaret M. Cortese, MD Centers for Disease Control and Prevention 12 th International Rotavirus Symposium, Melbourne, AUST Sept. 7, 2016
More informationPopulation- Based Surveillance of Infectious Diseases in Private Hospitals in Damanhour District, Egypt. Background
Population- Based Surveillance of Infectious Diseases in Private Hospitals in Damanhour District, Egypt Background Infectious diseases, such as tuberculosis, lower respiratory infections and diarrheal
More informationDoes Rota Vaccine Reduce Attacks of Acute Gastroenteritis among Children Under 15 Months of Age?
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 10 (2017) pp. 1178-1184 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2017.610.142
More informationFrequently asked questions (FAQs) on MR vaccination campaign. Training Workshop for Measles-Rubella Vaccination Campaigns
Frequently asked questions (FAQs) on MR vaccination campaign Training Workshop for Measles-Rubella Vaccination Campaigns What are measles/rubella diseases? Measles is a highly infectious disease causing
More informationBurden of Paediatric Rotavirus Gastroenteritis & Potential Impact of Rotavirus Vaccination
Carlo GIAQUINTO Pediatrics Department University of Padova, Italy Burden of Paediatric Rotavirus Gastroenteritis & Potential Impact of Rotavirus Vaccination Preliminary results 7th International Rotavirus
More informationCOUNTRY SITUATION UPDATES: Cholera. Philippines
COUNTRY SITUATION UPDATES: Cholera Philippines Outline of Presentation Cholera Epidemiology Updates Progress in the Prevention & Control Country Capacities Number of Cases Fig. 1 Confirmed Cholera Cases
More informationRotavirus. Rotavirus. Vaccine-Preventable Diseases WHO Vaccine-Preventable Diseases Surveillance Standards. Surveillance Standards
Last updated: September 5, 2018 Vaccine-Preventable Diseases Surveillance Standards 1 DISEASE AND VACCINE CHARACTERISTICS, a member of the reovirus family, causes watery diarrhoea, vomiting and severe
More informationSummary of WHO Position on Rotavirus. Narendra K. Arora SAGE Member Executive Director The INCLEN Trust International New Delhi (India)
Summary of WHO Position on Rotavirus Narendra K. Arora SAGE Member Executive Director The INCLEN Trust International New Delhi (India) Presentation WHO Position Papers on Rotavirus Optimizing immunization
More informationAPPENDIX 4 A4.1 APPENDIX 4
APPENDIX 4 A4.1 APPENDIX 4 APPENDIX 4 A4.3 DEFINITIONS OF THE INDICATORS 1.1 BCG coverage Number 12 23-month-olds receiving BCG vaccine before 1st birthday 1 1.2 DPT coverage Number 12 23-month-olds receiving
More informationIASR Back Number Vol.35. The Topic of This Month Vol.35 No.3 (No.409) Rotavirus, , Japan. (IASR 35: 63-64, March 2014) Phoca PDF
The Topic of This Month Vol.35 No.3 (No.409) Rotavirus, 2010-2013, Japan (IASR 35: 63-64, March 2014) Rotavirus belongs to the family Reoviridae, whose genome consists of 11 segments of double-stranded
More informationBULLETIN. World Health Organization, Western Pacific Regional Office, Manila, Philippines Issue 8 January 2006 ISSN
BULLETIN World Health Organization Regional Office for the Western Pacific Expanded Programme on Immunization World Health Organization, Western Pacific Regional Office, Manila, Philippines Issue 8 January
More informationAvailability of safe drinking-water: the answer to cholera outbreak? Nabua, Camarines Sur, Philippines, 2012
Outbreak Investigation Report Availability of safe drinking-water: the answer to cholera outbreak? Nabua, Camarines Sur, Philippines, 2012 Alethea De Guzman, ab Vikki Carr de los Reyes, b Ma Nemia Sucaldito
More informationFecal shedding of rotavirus vaccine in premature babies in the neonatal unit
Fecal shedding of rotavirus vaccine in premature babies in the neonatal unit Dr. Manish Sadarangani Director, Vaccine Evaluation Center, BC Children s Hospital Research Institute Assistant Professor, Division
More informationAssessing public health impact through vaccine probe analyses. Robert F. Breiman Emory Global Health Institute Emory University
Assessing public health impact through vaccine probe analyses Robert F. Breiman Emory Global Health Institute Emory University State of understanding the relative role of pathogens in major disease syndromes
More informationAccess to vaccination in GAVI countries and at global level
Access to vaccination in GAVI countries and at global level Stefano Malvolti Director, Vaccine Implementation GAVI Alliance 15th ADVANCED COURSE OF VACCINOLOGY May 12, 2014 Global progress to MDG 4 for
More informationHow to move from data to implementation. Dr. Tajul Islam A Bari MOH&FW, Bangladesh
How to move from data to implementation Dr. Tajul Islam A Bari MOH&FW, Bangladesh Preparation for RVV introduction The country has taken steps towards closing the RV immunization gap and protect all children
More informationRotavirus Vaccines. Gagandeep Kang Christian Medical College Vellore
Rotavirus Vaccines Gagandeep Kang Christian Medical College Vellore Rotavirus disease burden Rotavirus vaccines and candidates Performance of vaccines in developed and developing countries Longitudinal
More informationRotavirus Vaccine and Health Care Utilization for Diarrhea in U.S. Children
T h e n e w e ngl a nd j o u r na l o f m e dic i n e original article Rotavirus Vaccine and Health Care Utilization for Diarrhea in U.S. Children Jennifer E. Cortes, M.D., Aaron T. Curns, M.P.H., Jacqueline
More informationD.A.Henderson, MD, MPH. Professor of Medicine, University of Pittsburgh Honorary Fellow, London School of Hygiene and Tropical Medicine
Polio Eradication a reconsideration of strategy D.A.Henderson, MD, MPH Professor of Medicine, University of Pittsburgh Honorary Fellow, London School of Hygiene and Tropical Medicine Baltimore, Maryland
More informationNoroviruses. Duncan Steele Bill & Melinda Gates Foundation. Acknowledgements: Ben Lopman and Umesh Parashar, CDC Megan Carey and Julia Bosch, BMGF
Noroviruses Duncan Steele Bill & Melinda Gates Foundation Acknowledgements: Ben Lopman and Umesh Parashar, CDC Megan Carey and Julia Bosch, BMGF 1 Global norovirus burden Globally, norovirus is associated
More informationdeveloping countries in Latin America?
. How have rotavirus vaccines worked in developing countries in Latin America? Brendan Flannery, Pan American Health Organization, Brazil and Lúcia De Oliveira, Immunization Unit/FCH, Washington, DC 9th
More informationExpanded Programme on Immunization
1 Expanded Programme on Immunization Strategic issues Immunization is a cost-effective public health intervention that has dramatically reduced disease, disability and death in the Western Pacifi c Region.
More informationDescriptive epidemiology of rotavirus infection in a community in North India
Epidemiol. Infect., Page of 7. f Cambridge University Press 20 doi:0.07/s095026882002762 Descriptive epidemiology of rotavirus infection in a community in North India T. R. CHANDOLA,S.TANEJA, N. GOYAL,
More informationObjectives of Rotavirus Surveillance
Objectives of Rotavirus Surveillance Contribute data to estimate the burden of rotavirus diarrhea in children < 5 children Document circulating rotavirus strains in the AFR region Support awareness and
More informationTowards the Achievement of GHSA 2024 s Overarching Targets
정보화파트업무계획 [GHSA] Immunization Towards the Achievement of GHSA 2024 s Overarching Targets 2016년추진업무및 2017년업무계획 ( 사업관리 ) 7 th November 2018 Korea Centers for Disease Control and Prevention I. Overview Contents
More informationSupplementary appendix: Oral polio vaccination and hospital admissions with non-polio infections in Denmark: Nationwide retrospective cohort study
Supplementary appendix: Oral polio vaccination and hospital admissions with non-polio infections in Denmark: Nationwide retrospective cohort study Signe Sørup, Lone G. Stensballe, Tyra G. Krause, Peter
More informationROTAVIRUS VACCINE, LIVE, ORAL, PENTAVALENT
ROTAVIRUS VACCINE, LIVE, ORAL, PENTAVALENT RotaTeq Solution for Oral Administration THERAPEUTIC CLASS ROTAVIRUS VACCINE, LIVE, ORAL, PENTAVALENT hereafter referred to as PENTAVALENT ROTAVIRUS VACCINE (RotaTeq),
More informationClosing MR Immunity Gaps Experiences from the Regions Sri Lanka
Closing MR Immunity Gaps Experiences from the Regions Sri Lanka Dr. Paba Palihawadana Chief Epidemiologist Epidemiology Unit Ministry of Health Sri Lanka Background of the National Immunization Programme
More informationChallenges of building a new vaccine delivery platform for LMICs
Challenges of building a new vaccine delivery platform for LMICs Terri B. Hyde, MD MPH Immunizations Systems Branch, GID, CDC 23 March 2017 Immunization in the Elderly Geneva, Switzerland What has been
More informationDr Michelle Groome MBBCh (Wits) DCH(SA) MScMed (Epi & Biostats) Department of Science and Technology/National Research Foundation: Vaccine
Dr Michelle Groome MBBCh (Wits) DCH(SA) MScMed (Epi & Biostats) Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases; Medical Research Council: Respiratory and
More informationRoutine Immunization Status among Children under 5 Years of Age living in Rural District of Pakistan
International Journal of Health Research and Innovation, vol. 3, no. 2, 2015, 13-20 ISSN: 2051-5057 (print version), 2051-5065 (online) Scienpress Ltd, 2015 Routine Immunization Status among Children under
More informationA Briefing Paper on Rotavirus
COMMON VIRUS AND SENSELESS KILLER: A Briefing Paper on Rotavirus DIARRHEA KILLS. MOTHERS IN THE WORLD S POOREST COUNTRIES KNOW THIS ALL TOO WELL. It s a fact few people in wealthier nations realize. Rotavirus
More informationDefining incidence of intussusception (IS) in Bangladesh in preparation for a phase III trial of a new Rotavirus vaccine
Defining incidence of intussusception (IS) in Bangladesh in preparation for a phase III trial of a new Rotavirus vaccine Principal Investigator: Dr. K. Zaman Final Report June 1, 2007 1 This study was
More informationPoliomyelitis: successful and critical issues in the eradication process
Vaccine Preventable Diseases in the Mediterranean Basin and Black Sea: immunization strategies and coverage in the general population and the newly arrived migrants the ProVacMed project Poliomyelitis:
More informationMY DISSERTATION PROCESS & EFFECTIVENESS OF ROTAVIRUS VACCINES IN LOW- INCOME SETTINGS
MY DISSERTATION PROCESS & EFFECTIVENESS OF ROTAVIRUS VACCINES IN LOW- INCOME SETTINGS MARCH 3, 2017 LAUREN M. SCHWARTZ, MSPH PHD CANDIDATE LAURENMS@UW.EDU OUTLINE FOR TODAY What do you want to get out
More informationRotavirus, the most common cause of severe diarrhea in infants
Original Studies Hospital-based Surveillance for Rotavirus Gastroenteritis Among Young Children in Bangladesh Defining the Potential Impact of a Rotavirus Vaccine Program Syed M. Satter, MBBBS, MPH,* Paul
More informationDisease Control Priorities. Presentation Sub-title Seventh International Rotavirus Symposium Lisbon June 12, 2006
Disease Control Priorities and Rotavirus Presentation Vaccines Title Presentation Sub-title Seventh International Rotavirus Symposium Lisbon June 12, 2006 1 What is the DCPP? DCPP is an alliance of organizations
More informationLessons from Rotavirus Vaccine Implementation in the U.S.
Lessons from Rotavirus Vaccine Implementation in the U.S. Jeff Duchin, MD Chief, Communicable Disease Epidemiology & Immunization Section Public Health - Seattle & King County Professor in Medicine, Division
More informationThailand Expanded Program on Immunization. Suchada Jiamsiri, MD, MPH Division of Vaccine Preventable Diseases Ministry of Public Health, Thailand
Thailand Expanded Program on Immunization Suchada Jiamsiri, MD, MPH Division of Vaccine Preventable Diseases Ministry of Public Health, Thailand Outline Expanded Program on Immunization Organization Immunization
More informationHBV vaccination: Optimizing coverage and efficacy. Alex Vorsters, Pierre Van Damme Viral Hepatitis Prevention Board
HBV vaccination: Optimizing coverage and efficacy. Alex Vorsters, Pierre Van Damme Viral Hepatitis Prevention Board 2 nd Hepatitis Cure and Eradication Meeting 11 12 November 2015 Declaration of Interest
More informationKaren L. Kotloff, MD on behalf of the VIDA consortium 13 th International Rotavirus Symposium Minsk, Belarus August 2018
Etiology of diarrheal disease after rotavirus vaccine introduction: The Vaccine Impact on Diarrhea in Africa (VIDA) Study Karen L. Kotloff, MD on behalf of the VIDA consortium 13 th International Rotavirus
More information16 HIV/AIDS Infection and Cell Organelles ALTHOUGH MANY OF their characteristics are similar to those of cells, viruses
16 HIV/AIDS Infection and Cell Organelles ALTHOUGH MANY OF their characteristics are similar to those of cells, viruses are not cells. They contain genetic material and a few proteins, but they do not
More informationThe Pentavalent Rotavirus Vaccine, RotaTeq : From Development to Licensure and Beyond
The Pentavalent Rotavirus Vaccine, RotaTeq : From Development to Licensure and Beyond Max Ciarlet, PhD Vaccines Clinical Research Department Merck Research Laboratories North Wales, Pennsylvania, United
More informationWhy does Diarrhea matter? PREVENTING MORE THAN ONE MILLION UNNECESSARY DEATHS EVERY YEAR
Why does Diarrhea matter? PREVENTING MORE THAN ONE MILLION UNNECESSARY DEATHS EVERY YEAR Presentation made at CORE GROUP on February 16, 2012 Dyness Kasungami, Child Health Team Leader, MCHIP Presentation
More informationBangladesh: How to move from data to implementation. K. Zaman, MBBS, PhD Senior Scientist and Epidemiologist icddr,b
Bangladesh: How to move from data to implementation K. Zaman, MBBS, PhD Senior Scientist and Epidemiologist icddr,b Rotavirus in Bangladesh Estimated 2.4 million cases of rotavirus diarrhoea annually in
More informationGSK Medicine: Rotarix (HRV): GlaxoSmithKline Biologicals live attenuated human rotavirus vaccine Study No.: (EPI-ROTA ) Title:
GSK Medicine: Rotarix (HRV): GlaxoSmithKline Biologicals live attenuated human rotavirus Study No.: 111426 (EPI-ROTA-111426) Title: Case-control study to evaluate the effectiveness of GlaxoSmithKline (GSK)
More informationHepatitis B vaccination worldwide: Lessons learnt and the way forward
Hepatitis B vaccination worldwide: Lessons learnt and the way forward VHPB Russia meeting Oct 2018 Pierre Van Damme MD, PhD History Hepatitis B vaccines have been available since early 1980 s First recommended
More informationUpdates on Rotasiil development
Updates on Rotasiil development 13 th International Rotavirus Symposium Minsk, Belarus 30 August 2018 Dr Sajjad Desai MD Serum Institute of India Pvt Limited, Pune Rotasiil Bovine-human reassortant strains
More informationTotal population 1,265,308,000. Live births (LB) 27,016,000. Children <1 year 25,928,200. Children <5 years 23,818,000. Children <15 years 25,639,000
India 4 Immunization system highlights There is a comprehensive multiyear plan (cmyp) for immunization covering 3-7. National technical advisory group on immunization (NTAGI) exists and formal written
More informationin control group 7, , , ,
Q1 Rotavirus is a major cause of severe gastroenteritis among young children. Each year, rotavirus causes >500,000 deaths worldwide among infants and very young children, with 90% of these deaths occurring
More informationV A C C I N E H E S I TA N C Y :
V A C C I N E H E S I TA N C Y : T H E R O L E O F C O N V E N I E N C E T H E O R E T I C A L A S P E C T S A N D I S S U E S I N C A N A D A S H A N N O N M A C D O N A L D P H D, RN U N I V E R S I
More informationHepatitis B birth dose vaccination: coverage and barriers to timely vaccination in the Mekong River delta, Vietnam
Hepatitis B birth dose vaccination: coverage and barriers to timely vaccination in the Mekong River delta, Vietnam Tam Thi Pham, Huu Minh Le, Dat Tan Nguyen, Can Tho University of Medicine and Pharmacy,
More informationTotal population 1,212,110. Live births (LB) 43,924. Children <1 year 40,351. Children <5 years 192,340. Children <15 years 510,594
Draft version for the SEAR-ITAG 5-9 June 5 All data provisional as of May 5 Timor Leste 4 Immunization system highlights There is a comprehensive multi-year plan (cmyp) for immunization covering 3-5. 8%
More informationHarnessing the power of vaccines using the public and private sector: A 21 st century model for international development
Harnessing the power of vaccines using the public and private sector: A 21 st century model for international development Dr. Seth Berkley, CEO GAVI Alliance Wellcome Trust Cambridge Centre for Global
More informationEdwin J. Asturias Associate Director
Edwin J. Asturias Associate Director Center for Global Health Associate Professor of Pediatrics and Epidemiology Effectiveness Dengue Vaccine Washington DC, June 2014 UNIVERSITY OF COLORADO COLORADO STATE
More informationCan we improve the performance of live oral rotavirus vaccines?
Can we improve the performance of live oral rotavirus vaccines? Duncan Steele 9 th International Rotavirus Symposium 2 & 3 August 2010, Johannesburg, South Africa Vaccine efficacy against severe rotavirus
More informationGOAL 2: ACHIEVE RUBELLA AND CRS ELIMINATION. (indicator G2.2) Highlights
GOAL 2: ACHIEVE RUBELLA AND CRS ELIMINATION (indicator G2.2) Highlights As of December 2014, 140 Member States had introduced rubella vaccines; coverage, however, varies from 12% to 94% depending on region.
More informationMY DISSERTATION PROCESS & EFFECTIVENESS OF ROTAVIRUS VACCINES IN LOW- INCOME SETTINGS
MY DISSERTATION PROCESS & EFFECTIVENESS OF ROTAVIRUS VACCINES IN LOW- INCOME SETTINGS MARCH 2, 2018 LAUREN M. SCHWARTZ, MSPH PHD CANDIDATE LAURENMS@UW.EDU OUTLINE FOR TODAY What do you want out of your
More informationSummary of Key Points. WHO Position Paper on Vaccines against Hepatitis B, July 2017
Summary of Key Points WHO Position Paper on Vaccines against Hepatitis B, July 2017 1 Background l HBV is transmitted by exposure of mucosal membranes or non-intact skin to infected blood, saliva, semen
More informationA C T I O N T O A D D R E S S P N E U M O N I A A N D D I A R R H O E A
A C T I O N T O A D D R E S S P N E U M O N I A A N D D I A R R H O E A Integrated Global Action Plan for the Prevention and Control of Pneumonia and Diarrhoea: Frequently Asked Questions Document for
More informationWASH and Nutrition Situation in Nepal
WASH and Nutrition Situation in Nepal Coverage of Water Supply: 87% (DWSS 2016) Coverage of Sanitation: 92% (DWSS 2017) Households with specific place for hand washing with soap and water: 73% (MICS 2014)
More informationEfficacy of the pentavalent rotavirus vaccine, RotaTeq, in Finnish infants up to 3 years of age: the Finnish Extension Study
Eur J Pediatr (2010) 169:1379 1386 DOI 10.1007/s00431-010-1242-3 ORIGINAL PAPER Efficacy of the pentavalent rotavirus vaccine, RotaTeq, in Finnish infants up to 3 years of age: the Finnish Extension Study
More informationImpact of Immunization on Under 5 Mortality
Annals of Community Health (AoCH) pissn 2347-5455 eissn 2347-5714 An Indexed (Index Medicus, DOAJ and More), Peer Reviewed, Quarterly, International Journal focusing exclusively on Community Medicine and
More informationAre You Ready to Sail. February 11, 2016
Are You Ready to Sail your SHIP?! February 11, 2016 Acknowledgement and Disclaimer This webinar was supported by funds made available from the Centers for Disease Control and Prevention, Office for State,
More information3. CONCLUSIONS AND RECOMMENDATIONS
3. CONCLUSIONS AND RECOMMENDATIONS 3.1 Polio Endgame Strategy Conclusions 1. The TAG welcomes the RCC conclusion that Western Pacific Region maintains its polio-free status, and commends China for the
More informationROTAVIRUS VACCINES. Virology
ROTAVIRUS VACCINES Virology Rotavirus is a triple-layers viral particle belonging to the Reoviridae family. It contains 11 segments of double-stranded RNA, of which 6 are structural and 5 are non-structural
More informationTanzania s Progress in Combating Malaria: Achievement and Challenges
Tanzania s Progress in Combating Malaria: Achievement and Challenges DR RENATA A MANDIKE DEPUTY PROGRAMME MANAGER NATIONAL MALARIA CONTROL PROGRAMME, MINISTRY OF HEALTH, COMMUNITY DEVELOPMENT, GENDER,
More informationCountry spotlight: Fiji
Country spotlight: Fiji Fiona Russell, Centre for International Child Health, WHO Collaborating Centre for Research & Training in Child & Neonatal Health, Dept of Paediatrics, The University of Melbourne
More informationAfghanistan: WHO and UNICEF estimates of immunization coverage: 2017 revision
Afghanistan: WHO and UNICEF estimates of immunization coverage: 2017 revision July 7, 2018; page 1 WHO and UNICEF estimates of national immunization coverage - next revision available July 15, 2019 data
More informationMaternal influenza immunisation
Maternal influenza immunisation Cheryl Cohen Centre Head Centre for Respiratory Disease and Meningitis, National Institute for Communicable Diseases cherylc@nicd.ac.za Global causes of death in children
More informationHIV/AIDS and ART Registry of the Philippines (HARP)
HIV/AIDS and ART Registry of the Philippines (HARP) Number of Cases Department of Health Epidemiology Bureau FEBRUARY 215 28 21 212 214 215 Number of Newly Diagnosed with HIV per day: 1 4 9 17 2 NEWLY
More informationArizona Health Improvement Plan
Arizona Health Improvement Plan Arizona Alliance for Community Health Centers February 4, 2015 Will Humble, MPH ADHS Director Leading Health Issues State Health Assessment Obesity Behavioral Health Services
More informationNIGERIA ROUTINE IMMUNIZATION IN NIGERIA. 31% of children who received the 1st dose of pentavalent vaccine did not get all 3 doses
MICS/NICS 206/7 NIGERIA 206 207 PROGRESS TOWARD GVAP GOALS Penta3 coverage 00% goal 90% goal States with 80% penta3 coverage NATIONAL IMMUNIZATION COVERAGE SURVEY (NICS): National Brief ROUTINE IMMUNIZATION
More informationADVOCACY LESSONS FROM THE PHILIPPINES PROF EMERITUS LULU C BRAVO UNIVERSITY OF THE PHILIPPINES MANILA
ADVOCACY LESSONS FROM THE PHILIPPINES PROF EMERITUS LULU C BRAVO UNIVERSITY OF THE PHILIPPINES MANILA What is Advocacy? How Can it Help Us Achieve Our Goal? What is Advocacy? The act of supporting a cause,
More informationGlobal Update. Reducing Mortality From Major Childhood Killer Diseases. infant feeding, including exclusive breastfeeding.
INDIAN PEDIATRICS VOLUME 35-FEBRUARY 1998 Global Update Reducing Mortality From Major Childhood Killer Diseases Seven out of 10 childhood deaths in developing countries can be attributed to just five main
More informationWHO Rotavirus Vaccine Update Dr. Fatima Serhan WHO/FWC/IVB/EPI
WHO Rotavirus Vaccine Update 2012 Dr. Fatima Serhan WHO/FWC/IVB/EPI WHO estimates that 453 000 child deaths occurred during 2008 due to rotavirus infection 41057 32653 39144 98621 82% of these deaths occurred
More informationCommon Virus and Senseless Killer: A Briefing Paper on Rotavirus
Common Virus and Senseless Killer: A Briefing Paper on Rotavirus Diarrhea kills. Mothers in the world s poorest countries know this all too well. It s a fact few people in wealthier nations realize. Rotavirus
More informationUS Rotavirus Vaccination Program
US Rotavirus Vaccination Program 1 Rotavirus Vaccines in US Feb 2006 Feb 2006 April 2008 June 2008 RotaTeq licensed by FDA RotaTeq recommended by ACIP Rotarix licensed by FDA ACIP to consider Rotarix 2
More information